P atients with moderate to severe depression are being recruited for a 12-week group program that treats the condition with cognitive behavior (CBT) therapy. The group will be led by Robbi Saletsky PhD, a clinical psychologist and clinical assistant professor in Upstate's Department of Psychiatry, and an advanced-level psychiatric resident.
"A great deal of the research literature establishes CBT as the talk therapy of choice for depression," Dr. Saletsky reports. "While antidepressant medication can be extremely helpful, CBT has been shown to help minimize relapse in the long run. Learning practical, self-initiated strategies -that show results -tends to give patients a tremendous sense of mastery."
The 12-week CBT group will use an established, empirically validated protocol to introduce patients to practical skills aimed at decreasing symptoms of depression. The sessions will be augmented by a patient manual, with review material and at-home practice assignments.
Errors in Perception
Clinically depressed patients are prone to negative thoughts and often jump to negative conclusions, even with no evidence to support them. According to Dr. Saletsky, CBT helps patients recognize and minimize their negative responses. "The goal is not to eliminate all negative thoughts," she says. "The goal is not to give those negative thoughts as much value. Patients become aware of what they're doing to themselves and develop more constructive reactions."
Since patients with depression can be socially isolated and low in assertiveness skills, they often respond well to group therapy. "It's helpful for these patients to interact with others," Dr. Saletsky says. "Watching others make progress toward their goals can increase their own motivationand the likelihood that they'll become more active."
Antidepressants, As Needed
Candidates for the 12-week group therapy program will be evaluated by Dr. Saletsky for symptoms of depression (see Physicians' Alert, opposite page). "Patients may already be on antidepressant medication, or they may be placed on antidepressants (per their physician's recommendation) prior to joining the group, especially if they are too depressed to make use of CBT strategies," she notes. "Others may benefit more from an individual therapy approach."
Health insurance carriers often cover CBT group treatment for depression. "The CBT approach is very much liked by managed care companies," Dr. Saletsky reports, "because CBT is time-limited, research-validated and effective."
For more information or to refer a patient to the 12-week group therapy program, please contact Dr. Robbi Saletsky in SUNY Upstate's Adult Psychiatry Clinic, 315-464-3115. Depression affects approximately 19 million Americans, or 9.5 percent of the population in any given one-year period. At some point in their lives, ten to 25 percent of women and five to 12 percent of men will likely become clinically depressed.
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According to SUNY Upstate's Robbi Saletsky PhD, a clinical psychologist, 80 to 90 percent of those who seek treatment for depression can feel better within just a few weeks. "But for a variety of reasons, many people do not seek treatment for depression," she says. "Some believe that depression is the result of a personal weakness or character flaw. This is simply not true. Like diabetes, heart disease or any other medical condition, clinical depression is an illness that should be treated."
Another reason for not seeking help is that many people do not recognize the signs or symptoms of depression. "That's why it's vitally important for their primary care physicians to be aware of the physical and psychological symptoms of depression," she adds.
Primary-care physicians are often the first line of treatment for patients with depression. "Patients often go to their doctors complaining of chronic headache or abdominal distress -physical symptoms that are often associated with depression," says Dr. Saletsky, who offers the above diagnostic criteria for major depression.
PHYSICAL SYMPTOMS:
•Sleep disturbance
•Significant weight loss/gain or change in appetite
•Anxiety (dry mouth, diarrhea, cramps, sweating, etc.)
•Fatigue, low energy
•Inability to concentrate, make decisions or think clearly PSYCHOLOGICAL SYMPTOMS:
•Depressed mood Dr. Clarke, who studied and trained at the University of Cambridge and University of Oxford in England, offers a number of cutting-edge approaches to joint reconstruction, including minimally invasive hip and knee replacements, which reduce incision size and patient discomfort, shorten hospital stays and accelerate recovery.
"Keyhole" Procedure
Dr. Clarke also performs "keyhole" arthroscopy for hip evaluations, having trained under one of the world's foremost authorities in this procedure, Richard Villar. These endoscopic examinations "allow us to have a very good look at the damaged joint," Dr. Clarke reports. "They provide an interior view that is far superior to an MRI. Often, we can clean up some of the damage and prevent or postpone hip replacement." University Hospital has recently purchased a $10,000 specialized hip distractor for this procedure.
For patients at high risk of damaging hip arthritis -such as those with hip dysplasia or other malformations of the hip -Dr. Clarke also performs pelvic osteotomy. This joint conservation procedure involves redirecting the acetabulum to distribute the pressure more evenly. The intent is to relieve pain in early-to moderate-arthritis and postpone or even prevent the need for a hip replacement. "It's a significant operation," Dr. Clarke notes. "But it can delay hip replacement by 10 to 15 years. It's widely used in Europe as a preventive measure and is increasing in popularity here in the USA."
Clinical Trials
Dr. Clarke is currently involved in two major clinical trials of cutting-edge implants that are not widely available. The first is a novel knee replacement known as the Zimmer Hi-Flex mobile bearing knee, intended for patients who need to obtain the best possible flexion after knee surgery. "The implant design combines several new features to maximize a patient's chance of obtaining an excellent range of motion after surgery," he explains.
Dr. Clarke's second clinical trial involves resurfacing arthroplasty, a bone-conserving alternative to a total hip replacement. Aimed at younger, active patients, the trial is studying The Cormet 2000, a replacement that simply resurfaces the hip ball and socket joint, rather than violating the marrow cavity like a full hip replacement. According to Dr. 
IHP:
A Major Advantage T he rehabilitation and research facilities at SUNY Upstate's Institute for Human Performance (IHP) played a major role in attracting Dr. Clarke to Syracuse. His joint replacement patients can take advantage of the IHP's state-of-theart exercise and aquatic therapies. And Dr. Clarke's research interestsparticularly his commitment to "making a better artificial hip" -will take full advantage of the IHP's advanced research technology. "The IHP has a $75,000 computercontrolled machining center to produce better bearing surfaces for research," Dr. Clarke explains.
The IHP is also home to one of nation's rare radiostereometric analysis (RSA) machines, which uses multiple x-ray images to measure minute changes in motion between joint replacements and the surrounding bone. The RSA machine has been validated as an excellent tool for identifying the joint replacements that are likely to perform best in the long run. "Dr. Scheinman brings exceptional accomplishments and abilities to this position," said Dr. Eastwood. "He is a remarkably talented medical scientist, a gifted educator and a highly respected physician. I look forward to working with Dr. Scheinman to achieve the goals we have set to make SUNY Upstate a first-tier, nationally recognized academic medical center."
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In accepting the dean's post, Dr. Scheinman said, "I am honored and excited to be asked to serve Upstate in this important role. We have a wonderful faculty and staff, and talented students. This is a campus full of energy and ideas, and I am confident that together we can chart a course to bring us a future of growth and opportunity."
As dean and executive vice president, Dr. Scheinman will oversee a college that has gained significant ground in attracting top-tier medical students and increased research funding. Last fall the college enrolled its top academically performing class in the last decade and continues to see increases in applications. On the research front, SUNY Upstate faculty have increased their research productivity, 
